Astellas Pharma Canada Inc
- C01 - Terapia cardíaca
- ADENOCARD PREFILLED SYRINGE solution for injection 12 mg/4 ml
- ADENOCARD PREFILLED SYRINGE solution for injection 6 mg/2 ml
- D11 - Otros preparados dermatológicos
- PROTOPIC ointment 0.03%
- PROTOPIC ointment 0.1%
- G04 - Urológicos
- MYRBETRIQ prolonged-release tablet 25 mg
- MYRBETRIQ prolonged-release tablet 50 mg
- VESICARE film-coated tablet 10 mg
- VESICARE film-coated tablet 5 mg
- J02 - Antimicóticos de uso sistémico
- AMBISOME powder for solution for infusion 50 mg
- MYCAMINE powder for solution for infusion 100 mg
- MYCAMINE powder for solution for infusion 50 mg
- L02 - Terapia endocrina
- XTANDI capsule, soft 40 mg
- L04 - Inmunosupresores
- ADVAGRAF prolonged-release capsule, hard 0.5 mg
- ADVAGRAF prolonged-release capsule, hard 1 mg
- ADVAGRAF prolonged-release capsule, hard 3 mg
- ADVAGRAF prolonged-release capsule, hard 5 mg
- PROGRAF capsule, hard 0.5 mg
- PROGRAF capsule, hard 1 mg
- PROGRAF capsule, hard 5 mg
- PROGRAF solution for infusion 5 mg/1 ml
- M02 - Productos tópicos para dolor articular y muscular
- DICLOFENAC SODIUM ASTELLAS cutaneous spray, solution 4%